DiaMedica Therapeutics Inc. (DMAC) Corporate Subsidiaries
DiaMedica Therapeutics Inc. (DMAC) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: DMAC
CIK: 1401040
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: Z4
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Baker Tilly US, LLP
Auditor SinceSince 12/31/2020 12:00:00 AM
Lead Engagement PartnerJohn Dauwalter
Audit LocationMinneapolis, Minnesota, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-08-12 | 2026-08-10 | 4 Filing | 0001760123-26-000004 | View SEC Doc Filr Page |
| S-8 | 2026-08-11 | — | FORM S-8 | 0001437749-26-026864 | View SEC Doc Filr Page |
| 10-Q | 2026-08-10 | 2026-06-30 | FORM 10-Q | 0001437749-26-026792 | View SEC Doc Filr Page |
| 8-K | 2026-08-10 | 2026-08-10 | FORM 8-K | 0001437749-26-026790 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | 4 Filing | 0001759822-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | 4 Filing | 0001341125-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | 4 Filing | 0001376847-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | 4 Filing | 0001451038-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | 4 Filing | 0001872863-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | 4 Filing | 0001759855-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | 4 Filing | 0001760123-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | 4 Filing | 0001490476-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-03 | 2026-06-01 | 4 Filing | 0001643127-26-000002 | View SEC Doc Filr Page |
| 8-K | 2026-05-21 | 2026-05-20 | FORM 8-K | 0001437749-26-018106 | View SEC Doc Filr Page |
| 10-Q | 2026-05-06 | 2026-03-31 | FORM 10-Q | 0001437749-26-015220 | View SEC Doc Filr Page |
| 8-K | 2026-05-06 | 2026-05-06 | FORM 8-K | 0001437749-26-015218 | View SEC Doc Filr Page |
| ARS | 2026-04-01 | 2025-12-31 | ARS | 0001437749-26-010881 | View SEC Doc Filr Page |
| DEFA14A | 2026-04-01 | — | FORM DEFA14A | 0001437749-26-010880 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-01 | 2026-05-20 | FORM DEF 14A | 0001437749-26-010879 | View SEC Doc Filr Page |
| 8-K | 2026-03-31 | 2026-03-30 | FORM 8-K | 0001437749-26-010409 | View SEC Doc Filr Page |
| 10-K | 2026-03-30 | 2025-12-31 | FORM 10-K | 0001437749-26-010342 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-02-17 | — | SCHEDULE 13G/A Filing | 0000945621-26-000352 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-02-17 | — | SCHEDULE 13G/A Filing | 0000919574-26-001133 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-02-06 | — | SCHEDULE 13G/A Filing | 0001104659-26-011569 | View SEC Doc Filr Page |
| 4 | 2026-01-06 | 2026-01-02 | 4 Filing | 0001759855-26-000002 | View SEC Doc Filr Page |